{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:41:02Z","timestamp":1789062062718,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Down syndrome (DS) is a chromosomal anomaly that is characterized by an extra chromosome 21. Ophthalmological manifestations have a high prevalence in patients with DS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To review the scientific evidence and estimate the prevalence of ophthalmological manifestations in the pediatric population with DS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Data sources<\/jats:title>\n                <jats:p>Electronic databases including MEDLINE, Cochrane Library, EMBASE, ScienceDirect, and LILACS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study eligibility criteria<\/jats:title>\n                <jats:p>Published observational studies with available and original data were included. Articles were excluded if the study design was a review, letter to the editor, case report, case series, or systematic review and if the subjects had ophthalmological manifestations secondary to other conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Participants and interventions<\/jats:title>\n                <jats:p>Pediatric and adolescent population with DS and with ophthalmological evaluation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study appraisal and synthesis methods<\/jats:title>\n                <jats:p>A data collection form was designed in Excel. Five reviewers extracted relevant details about the design and results of each study. The quality of the studies was assessed by applying the\u00a0tools for systematic reviews of prevalence and incidence from the Joanna Briggs Institute. We calculated the weighted prevalence of ophthalmological manifestations, considering only the studies reporting the measurement of each manifestation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-two articles (from 15 countries, published during 1994\u20132020) were included in the present systematic review. Ocular manifestations were observed in 85% of the studied pediatric and adolescent populations with DS. The most frequent ones were slanting fissures, oblique fissures, epicanthus, and epiblepharon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The ocular manifestations in the pediatric and adolescent populations with DS are varied, and some can irreversibly affect visual development. Screening of the pediatric population with DS should be conducted from the first months of age and continued annually.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42019127717\">CRD42019127717<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-022-01940-5","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:06:18Z","timestamp":1650603978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of ophthalmological manifestations in pediatric and adolescent populations with Down syndrome: a systematic review of the literature"],"prefix":"10.1186","volume":"11","author":[{"given":"Juliana","family":"Mu\u00f1oz-Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas David","family":"Charry-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Bechara-Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Blanco-Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Talero-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Gomez-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-1989","authenticated-orcid":false,"given":"Alejandra","family":"de-la-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"1940_CR1","unstructured":"Down Syndrome - StatPearls - NCBI Bookshelf (n.d.).\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526016\/. Accessed 17 Jan\u00a02021."},{"key":"1940_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S2171-9748(09)70014-5","volume":"13","author":"C Claret-Torrents","year":"2009","unstructured":"Claret-Torrents C, Goday-Arno A, Cerd\u00e0-Esteve M, Flores-Le Roux J, Chillar\u00f3n-Jordan JJ, Cano-P\u00e9rez JF. Hyperthyroidism in Down syndrome. Int Med Rev Down Syndr. 2009;13:2\u20138. https:\/\/doi.org\/10.1016\/S2171-9748(09)70014-5.","journal-title":"Int Med Rev Down Syndr"},{"key":"1940_CR3","first-page":"125","volume":"5","author":"M Kazemi","year":"2016","unstructured":"Kazemi M, Salehi M, Kheirollahi M. Down syndrome: current status, challenges and future perspectives. Int J Mol Cell Med. 2016;5:125\u201333 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5125364\/. Accessed October 19, 2020.","journal-title":"Int J Mol Cell Med"},{"key":"1940_CR4","doi-asserted-by":"publisher","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in Europe. Eur J Hum Genet. 2020;1\u20139. https:\/\/doi.org\/10.1038\/s41431-020-00748-y.","DOI":"10.1038\/s41431-020-00748-y"},{"key":"1940_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G De Graaf","year":"2017","unstructured":"De Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19:439\u201347. https:\/\/doi.org\/10.1038\/gim.2016.127.","journal-title":"Genet Med."},{"key":"1940_CR6","first-page":"105","volume":"82","author":"J Nazer","year":"2011","unstructured":"Nazer J, Cifuentes L. Estudio epidemiol\u00f3gico global del s\u00edndrome de Down, Revista Chilena de. Pediatr\u00eda. 2011;82:105\u201312.","journal-title":"Pediatr\u00eda."},{"key":"1940_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jpeds.2013.11.032","volume":"164","author":"NJ Roizen","year":"2014","unstructured":"Roizen NJ, Magyar CI, Kuschner ES, Sulkes SB, Druschel C, van Wijngaarden E, et al. A community cross-sectional survey of medical problems in 440 children with Down syndrome in New York State. J Pediatr. 2014;164:871\u20135. https:\/\/doi.org\/10.1016\/j.jpeds.2013.11.032.","journal-title":"J Pediatr"},{"key":"1940_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mod.2008.11.002","volume":"126","author":"RJ Roper","year":"2009","unstructured":"Roper RJ, VanHorn JF, Cain CC, Reeves RH. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev. 2009;126:212\u20139.","journal-title":"Mech Dev"},{"key":"1940_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0940-9602(97)80010-6","volume":"179","author":"M Ludwig","year":"1997","unstructured":"Ludwig M, Busch L, Winking H. The embryonic development of sensory organs and the skull in the trisomy 16 mouse, an animal model for Down\u2019s syndrome. Ann Anat. 1997;179:525\u201333.","journal-title":"Ann Anat"},{"key":"1940_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/bjo.2007.124248","volume":"92","author":"C Parsa","year":"2008","unstructured":"Parsa C, Almer Z. Supranumerary optic disc vessels may indicate reduced systemic angiogenesis in Down syndrome. Br J Ophthalmol. 2008;92:432\u20133.","journal-title":"Br J Ophthalmol"},{"key":"1940_CR11","doi-asserted-by":"publisher","first-page":"14943","DOI":"10.1523\/JNEUROSCI.3728-10.2010","volume":"30","author":"K Gardiner","year":"2010","unstructured":"Gardiner K, Herault Y, Lott IT, Antonarakis SE, Reeves RH, Dierssen M. Down syndrome: from understanding the neurobiology to therapy. J Neurosci. 2010;30:14943\u20135.","journal-title":"J Neurosci"},{"key":"1940_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0002-9394(14)72015-X","volume":"122","author":"RP da Cunha","year":"1996","unstructured":"da Cunha RP, Moreira JB. Ocular findings in Down\u2019s syndrome. Am J Ophthalmol. 1996;122:236\u201344.","journal-title":"Am J Ophthalmol"},{"key":"1940_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2788.2008.01114.x","volume":"53","author":"HM Evenhuis","year":"2009","unstructured":"Evenhuis HM, Sjoukes L, Koot HM, Kooijman AC. Does visual impairment lead to additional disability in adults with intellectual disabilities? J Intellect Disabil Res. 2009;53:19\u201328. https:\/\/doi.org\/10.1111\/j.1365-2788.2008.01114.x.","journal-title":"J Intellect Disabil Res"},{"key":"1940_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"1940_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthcare. 2015;13:147\u201353.","journal-title":"Int J Evid Based Healthcare"},{"key":"1940_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/09273972.2019.1699582","volume":"28","author":"A Makateb","year":"2020","unstructured":"Makateb A, Hashemi H, Farahi A, Mehravaran S, Khabazkhoob M, Asgari S. Ocular alignment, media, and eyelid disorders in Down syndrome. Strabismus. 2020;28:42\u20138.","journal-title":"Strabismus."},{"key":"1940_CR17","doi-asserted-by":"publisher","unstructured":"Ugurlu A, Altinkurt E. Ophthalmologic manifestations and retinal findings in children with down syndrome. J Ophthalmol. 2020;2020:9726261. https:\/\/doi.org\/10.1155\/2020\/9726261.","DOI":"10.1155\/2020\/9726261"},{"key":"1940_CR18","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamaophthalmol.2013.644","volume":"131","author":"HH Afifi","year":"2013","unstructured":"Afifi HH, Abdel Azeem AA, El-Bassyouni HT, Gheith ME, Rizk A, Bateman JB. Distinct ocular expression in infants and children with Down syndrome in Cairo, Egypt: myopia and heart disease. JAMA Ophthalmol. 2013;131:1057\u201366. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.644.","journal-title":"JAMA Ophthalmol"},{"key":"1940_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3928\/01913913-20090301-04","volume":"46","author":"A Akinci","year":"2009","unstructured":"Akinci A, Oner O, Bozkurt OH, Guven A, Degerliyurt A, Munir K. Refractive errors and strabismus in children with down syndrome: a controlled study. J Pediatr Ophthalmol Strabismus. 2009;46:83\u20136. https:\/\/doi.org\/10.3928\/01913913-20090301-04.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1940_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/112067210701700521","volume":"17","author":"F Fimiani","year":"2007","unstructured":"Fimiani F, Iovine A, Carelli R, Pansini M, Sebastio G, Magli A. Incidence of ocular pathologies in Italian children with Down syndrome. Eur J Ophthalmol. 2007;17:817\u201322.","journal-title":"Eur J Ophthalmol"},{"key":"1940_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.eye.6700208","volume":"16","author":"JH Kim","year":"2002","unstructured":"Kim JH, Hwang J-M, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye (Lond). 2002;16:710\u20134. https:\/\/doi.org\/10.1038\/sj.eye.6700208.","journal-title":"Eye (Lond)"},{"key":"1940_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1469-8749.1994.tb11896.x","volume":"36","author":"NJ Roizen","year":"1994","unstructured":"Roizen NJ, Mets MB, Blondis TA. Ophthalmic disorders in children with Down syndrome. Dev Med Child Neurol. 1994;36:594\u2013600.","journal-title":"Dev Med Child Neurol"},{"key":"1940_CR23","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2147\/OPTH.S169107","volume":"12","author":"T Terai","year":"2018","unstructured":"Terai T, Eda S, Sugasawa J, Tonari M, Matsuo J, Oku H, et al. Ocular findings in Japanese children with Down syndrome: the course of visual acuity and refraction, and systemic and ocular anomalies. Clin Ophthalmol. 2018;12:1637\u201343. https:\/\/doi.org\/10.2147\/OPTH.S169107.","journal-title":"Clin Ophthalmol"},{"key":"1940_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0887-8994(97)00029-5","volume":"16","author":"V Wong","year":"1997","unstructured":"Wong V, Ho D. Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children. Pediatr Neurol. 1997;16:311\u20134. https:\/\/doi.org\/10.1016\/S0887-8994(97)00029-5.","journal-title":"Pediatr Neurol"},{"key":"1940_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.a.38043","volume":"173","author":"P Kruszka","year":"2017","unstructured":"Kruszka P, Porras AR, Sobering AK, Ikolo FA, La Qua S, Shotelersuk V, et al. Down syndrome in diverse populations. Am J Med Genet Part A. 2017;173:42\u201353.","journal-title":"Am J Med Genet Part A"},{"key":"1940_CR26","unstructured":"Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome, Singapore. Med J. 2006;47:14\u20139. https:\/\/www.sma.org.sg\/smj\/4701\/4701a1.pdf."},{"key":"1940_CR27","first-page":"2108","volume":"41","author":"JS Rahi","year":"2000","unstructured":"Rahi JS, Dezateux C. British Congenital Cataract Interest Group, Congenital and infantile cataract in the United Kingdom: underlying or associated factors. Invest Ophthalmol Vis Sci. 2000;41:2108\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1940_CR28","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/bjo.2006.090639","volume":"90","author":"B Haargaard","year":"2006","unstructured":"Haargaard B, Fledelius HC. Down\u2019s syndrome and early cataract. Br J Ophthalmol. 2006;90:1024\u20137. https:\/\/doi.org\/10.1136\/bjo.2006.090639.","journal-title":"Br J Ophthalmol"},{"key":"1940_CR29","first-page":"140","volume":"24","author":"LM Imbornoni","year":"2020","unstructured":"Imbornoni LM, Wise RE, Taravella MJ, Hickey F, McCourt EA. Keratoconus and corneal morphology in patients with Down syndrome at a pediatric hospital. JAAPOS. 2020;24:140\u2013e1.","journal-title":"JAAPOS."},{"issue":"9","key":"1940_CR30","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/ceo.13852","volume":"48","author":"JJ Mathan","year":"2020","unstructured":"Mathan JJ, Gokul A, Simkin SK, Meyer JJ, Patel DV, McGhee CN. Topographic screening reveals keratoconus to be extremely common in Down syndrome. Clin Exp Ophthalmol. 2020;48(9):1160\u20137. https:\/\/doi.org\/10.1111\/ceo.13852.","journal-title":"Clin Exp Ophthalmol."},{"key":"1940_CR31","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1167\/iovs.01-0131","volume":"44","author":"M Cregg","year":"2003","unstructured":"Cregg M, Woodhouse JM, Stewart RE, Pakeman VH, Bromham NR, Gunter HL, et al. Development of refractive error and strabismus in children with Down syndrome. Invest Ophthalmol Vis Sci. 2003;44:1023\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1940_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/bjo.85.6.714","volume":"85","author":"OH Haugen","year":"2001","unstructured":"Haugen OH, Hovding G, Lundstrom I. Refractive development in children with Down\u2019s syndrome: a population based, longitudinal study. Br J Ophthalmol. 2001;85:714\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1940_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/OPTO.S63351","volume":"7","author":"J-A Little","year":"2015","unstructured":"Little J-A. Accommodation deficit in children with Down syndrome: practical considerations for the optometrist. Clin Optom. 2015;7:81\u20139.","journal-title":"Clin Optom"},{"issue":"2","key":"1940_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1542\/peds.2011-1605","volume":"128","author":"Bull MJ; Committee on Genetics","year":"2011","unstructured":"Bull MJ; Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics. 2011;128(2):393\u2013406. https:\/\/doi.org\/10.1542\/peds.2011-1605.","journal-title":"Pediatrics."},{"key":"1940_CR35","first-page":"186","volume":"124","author":"OH Haugen","year":"2004","unstructured":"Haugen OH, H\u00f8vding G, Riise R. \u00d8yeforandringer ved Downs syndrom. Tidsskr Nor L\u00e6geforen. 2004;124:186\u20138.","journal-title":"Tidsskr Nor L\u00e6geforen."},{"key":"1940_CR36","doi-asserted-by":"crossref","unstructured":"Robinson J, Pompe MT, Gerth-Kahlert C. Challenges in patients with trisomy 21: a review of current knowledge and recommendations. J Ophthalmol. 2021;2021.","DOI":"10.1155\/2021\/8870680"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01940-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-022-01940-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01940-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:06:41Z","timestamp":1650604001000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-022-01940-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1940"],"URL":"https:\/\/doi.org\/10.1186\/s13643-022-01940-5","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}